AzTrials
AzTrials

Research institution

Children's National Research Institute Clinical Trials

Studies where Children's National Research Institute is the lead sponsor: what is enrolling now, by phase, condition and country.

127 registered studies

In numbers

Open to volunteers
44
Active
56
With results posted
13
All registered
127

Open to volunteers: recruiting, not yet recruiting or enrolling by invitation. Active adds studies under way that have stopped recruiting.

Open to volunteers

All 44
  • Solid Tumor

    Multi Tumor-Associated Antigen-Specific T Lymphocytes to Treat Patients With High Risk Solid Tumors

    • Recruiting
    • Age: 1 year to 70 years
    • Phase 1

    This is an open-label phase I dose-escalation study to evaluate the safety of partially human leukocyte antigen (HLA)-matched multi tumor-associated antigen-specific T cell (TAA-T) therapy following lymphodepleting conditioning…

    Trial name
    ATTACK (NCT05238792)
    Testing
    Tumor-associated antigen-specific T cell (TAA-T)
    Where
    United States
    Volunteers
    14 people
    Sponsor
    Children's National Research Institute
    Can I take part? ATTACK
  • Cleft Lip, Cleft Palate +/- Lip

    Comparative Study of Regional Nerve Blocks in Primary Cleft Palate Repair

    • Not yet recruiting
    • Age: 9 months and older
    • Surgery or procedure

    This study will evaluate whether adding a suprazygomatic maxillary nerve block to the standard palatal nerve block improves pain control after cleft palate repair surgery in children.

    Conditions
    Cleft Lip, Cleft Palate +/- Lip, Pain Management, Wound Dehiscence, Surgical
    Trial name
    NCT07892963
    Testing
    Palatal Nerve Block, Suprazygomatic Maxillary Nerve Block
    Volunteers
    144 people
    Sponsor
    Children's National Research Institute
    Can I take part? NCT07892963
  • Sexually Transmitted Diseases

    Using Mobile Health (mHealth) to Improve STI Treatment Adherence Among Adolescents

    • Recruiting
    • Age: 15 to 21 years
    • Lifestyle or therapy programme

    We will conduct a randomized trial to compare differences in sexually transmitted infection (STI) treatment adherence between patients receiving text messages versus those receiving usual care (e.g. no text messages).

    Trial name
    NCT04372485
    Testing
    mHealth Intervention
    Where
    United States
    Volunteers
    270 people
    Sponsor
    Children's National Research Institute
    Can I take part? NCT04372485
  • Cleft Lip, Cleft Lip Scar

    Cleft Lip Scarring After Botox

    • Recruiting
    • Age: 0 days to 12 months
    • Phase 2
    • Injection or infusion

    This study is investigating whether botulinum toxin type A (Botox) can improve scar appearance after cleft lip repair surgery. Cleft lip repair is commonly performed during infancy, but visible scarring can occur as the incision…

    Trial name
    CLSAB (NCT07880860)
    Testing
    Botulinum Toxin Type A (BOTOX) Injection, Normal Saline
    Where
    United States
    Volunteers
    40 people
    Sponsor
    Children's National Research Institute
    Can I take part? CLSAB
  • DMG, DIPG

    Blood-Brain Barrier Disruption Using Exablate Magnetic Resonance-Guided Low Intensity Focused Ultrasound With Microbubbles in Combination With T-Cell Infusion in Patients With Newly Diagnosed Diffuse Midline Glioma (LIFT)

    • Recruiting
    • Age: 3 to 25 years
    • Phase 1
    • Medical device

    This is an open-label phase 1 safety and feasibility study evaluating a novel combination therapy for Diffuse Midline Glioma (DMG), an aggressive brain tumor with a very poor prognosis - an average one-year overall survival.

    Trial name
    LIFT (NCT07796061)
    Testing
    TAA-T Cell, BBB Disruption
    Where
    United States
    Volunteers
    45 people
    Sponsor
    Children's National Research Institute
    Can I take part? LIFT
  • Medulloblastoma, Childhood, Atypical Teratoid/Rhabdoid Tumor of CNS

    Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)

    • Recruiting
    • Age: 1 year to 30 years
    • Phase 1
    • Surgery or procedure

    This is an open-label phase 1 safety and feasibility study that will employ multi-tumor antigen specific cytotoxic T lymphocytes (TSA-T) directed against proteogenomically determined personalized tumor-specific antigens (TSA)…

    Conditions
    Medulloblastoma, Childhood, Atypical Teratoid/Rhabdoid Tumor of CNS, Embryonal Tumor With Multilayered Rosettes, Pineoblastoma
    Trial name
    IMPACT (NCT06193759)
    Testing
    Multi-tumor antigen specific cytotoxic T lymphocytes (TSA-T) directed against proteogenomically determined personalized tumor-specific antigens (TSA), Group A Standard-of-Care Backbone Therapy, Group B Salvage Backbone Therapy
    Where
    United States
    Volunteers
    12 people
    Sponsor
    Children's National Research Institute
    Can I take part? IMPACT
  • Executive Function Deficits (EFD)

    Unstuck-Early Childhood Effectiveness & Implementation Trial

    • Not yet recruiting
    • Age: 4 to 5 years
    • Lifestyle or therapy programme

    The goal of this clinical trial is to learn if a new school-based, Tier 2 (selective) cognitive-behavioral intervention called Unstuck and On Target for Early Childhood (Unstuck-EC) can treat executive function deficits in young…

    Trial name
    NCT07832344
    Testing
    Unstuck and On Target for Early Childhood
    Volunteers
    90 people
    Sponsor
    Children's National Research Institute
    Can I take part? NCT07832344
  • Health Literacy, Comprehension

    Impact of AI Care Summaries on Caregiver Comprehension

    • Recruiting
    • Age: 18 years and older

    The primary objective is to assess if an AI-generated plain language summary of an inpatient progress note can improve caregiver understanding of their child's hospitalization by measuring differences in Hospital Course…

    Conditions
    Health Literacy, Comprehension, Patient Satisfaction
    Trial name
    NCT07831018
    Testing
    AI Care Summary
    Where
    United States
    Volunteers
    100 people
    Sponsor
    Children's National Research Institute
    Can I take part? NCT07831018
  • Diffuse Midline Glioma or Diffuse Intrinsic Pontine Glioma, High Grade Gliomas

    NgFUS NIVO: NeuroNavigation-Guided Focused Ultrasound With Nivolumab in Relapsed and Progressive DMG and Other High Grade Brain Tumors

    • Recruiting
    • Age: 3 to 25 years
    • Phase 1
    • Medical device

    This is an open-label phase 1 safety and feasibility study evaluating a novel combination therapy for progressive and relapsed diffuse midline glioma (DMG) and other progressive and relapsed high-grade brain tumors.

    Conditions
    Diffuse Midline Glioma or Diffuse Intrinsic Pontine Glioma, High Grade Gliomas, Medulloblastoma Recurrent, Ependymoma Recurrent
    Trial name
    NCT07664176
    Testing
    NeuroNavigation-Guided Focused Ultrasound (NgFUS), Lumason, Nivolumab
    Where
    United States
    Volunteers
    30 people
    Sponsor
    Children's National Research Institute
  • Turner Syndrome, Primary Ovarian Insufficiency

    Pre-pubertal Low Dose Transdermal Estradiol in Turner Syndrome

    • Not yet recruiting
    • Age: 8 to 12 years
    • Phase 2

    This is a research study to find out if treatment with transdermal estradiol patches started between 8 to 11.5 years is safe in girls with Turner syndrome who have ovarian failure and to see whether it may improve performance on…

    Trial name
    NCT07784582
    Testing
    Estradiol transdermal patch 0.025mg/24 hours- 1/8th fractionated patch
    Where
    United States
    Volunteers
    15 people
    Sponsor
    Children's National Research Institute
    Can I take part? NCT07784582

Completed, with results posted

All 12
  • Type 1 Diabetes, Continuous Glucose Monitoring

    Research on Optimizing the Use of Technology With Education

    • Completed
    • Age: 10 to 15 years
    • Lifestyle or therapy programme
    • Results posted

    Consistent use of continuous glucose monitors (CGM) has the potential to improve glycemic control and related type 1 diabetes (T1D) health outcomes, however young adolescents with T1D are the least likely age group to begin and…

    Conditions
    Type 1 Diabetes, Continuous Glucose Monitoring, Behavioral Intervention, Parent-Child Relations
    Trial name
    ROUTE-T1D (NCT05564481)
    Testing
    diabetes education and parent coaching support
    Where
    United States
    Volunteers
    60 people
    Sponsor
    Children's National Research Institute
    Can I take part? ROUTE-T1D
  • Type 1 Diabetes Mellitus

    Improving Health Communication During the Transition From Pediatric to Adult Diabetes Care

    • Completed
    • Age: 17 to 23 years
    • Lifestyle or therapy programme
    • Results posted

    Adolescents and young adults (AYAs; ages 17-23) with type 1 diabetes are at high risk for negative health outcomes, including poor glycemic control and disengagement from the health care system.

    Trial name
    NCT03734107
    Testing
    Plan, Reflect, and Engage with Providers for Diabetes Care
    Where
    United States
    Volunteers
    52 people
    Sponsor
    Children's National Research Institute
    Can I take part? NCT03734107
  • Type 1 Diabetes

    Group Visits for High Risk Type 1 Diabetes (T1D)

    • Completed
    • Age: 8 years and older
    • Lifestyle or therapy programme
    • Results posted

    The investigators propose to conduct a pilot prospective cohort study to assess the impact of shared medical appointments (SMA) visits in underserved youth with poorly controlled type 1 diabetes (T1D).

    Trial name
    NCT05431686
    Testing
    SMA visits
    Where
    United States
    Volunteers
    14 people
    Sponsor
    Children's National Research Institute
    Can I take part? NCT05431686
  • Rare Diseases

    FACE for Children With Rare Diseases

    • Completed
    • Age: 1 year to 99 years
    • Lifestyle or therapy programme
    • Results posted

    Children with ultra-rare or complex rare diseases are routinely excluded from research studies because of their conditions, creating a health disparity.

    Trial name
    FACE-Rare (NCT04855734)
    Testing
    FAmily CEntered (FACE) pACP Intervention
    Where
    United States
    Volunteers
    42 people
    Sponsor
    Children's National Research Institute
    Can I take part? FACE-Rare
  • type1diabetes

    Feasibility Trial of a Mindfulness Based Intervention in Youth With Type 1 Diabetes

    • Completed
    • Age: 12 to 17 years
    • Lifestyle or therapy programme
    • Results posted

    Type 1 diabetes (T1D) is one of the most common chronic illnesses of childhood. The involved treatment regimen, including daily insulin administration/pump management, frequent blood glucose checks, and careful track-ing of food…

    Trial name
    BREATHE-T1D (NCT05268393)
    Testing
    BREATHE-T1D
    Where
    United States
    Volunteers
    42 people
    Sponsor
    Children's National Research Institute

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in